Steven Baldwin is a partner in Kirkland’s IP Litigation team in London with significant experience representing clients in patent, life sciences regulatory, trademark, copyright and trade secrets matters. His practice focuses primarily on complex cross-border telecommunications (SEP/FRAND) and life sciences patent disputes and former employee trade secrets cases. Steven is at the very forefront of the continuing development of global FRAND case law, advising his clients on business critical worldwide disputes as global coordinating counsel (including, e.g., the UK, US, China, Germany, the Netherlands and Italy). Key recent cases include Sisvel and Mitsubishi v Xiaomi and others, InterDigital v Lenovo and Conversant v Huawei and ZTE. Steven has also developed a particular interest in, and deep knowledge of, the law governing supplementary protection certificates (SPCs) and has advised clients on SPC issues concerning numerous blockbuster small molecule and biologics products. He is recognised as a thought leader and regular writer, speaker and commentator on the topic.
Steven’s case experience covers a broad range of technical fields including 3GPP, 3GPP2, DMR, TETRA and other wireless (standardised and non-standardised) mobile telecommunications technologies, organic chemistry, antibody biologics, biological product development and screening platforms, formulation science, next generation cancer treatments, and e-cigarette/vaping technologies.
Kirkland & Ellis International LLP
EC3A 8AF London
+44 20 7953 2641